Clinical trial · Interventional
Comparison of Sevoflurane and Isoflurane Anesthesia for Benign Breast Tumor Excision
Anesthesia With Sevoflurane and Isoflurane for Excision Surgeries in Benign Breast Tumors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Generally, benign breast tumors are excised under the local anesthesia. But such action was so invasive that every patient would experience the physiological and psychological stimuli unavoidably. Sevoflurane was advised as a better inhalational anesthesic for its "easy come,easy go" property during short-lasting operations than isoflurane. We purposed that sevoflurane would be a superior anesthesic for benign breast tumor excision than isoflurane with relative less alteration in hemodynamics, less postoperative side effects and easily-control the depth of anesthesia.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Isoflurane | Drug | — | UNRESOLVED |
| Sevoflurane | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- 1
- description
- Sevoflurane: induction 3-6%, maintenance 2-3%
- interventionNames
- Drug: Sevoflurane
- type
- ACTIVE_COMPARATOR
- label
- 2
- description
- Isoflurane: induction 3-6%, maintenance 2-3%
- interventionNames
- Drug: Isoflurane
Primary outcomes (1)
- measure
- Time of induction, maintenance and resuscitation
- timeFrame
- 0h to the end of the operation
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 64 Years
Show eligibility criteria text
Inclusion Criteria: * Chinese * Diagnosed benign breast tumor patients * 18-64 yrs Exclusion Criteria: * Allergic to any interventional drugs * Organic dysfunction * Long-lasting PACU staying
References
Publications (0)
Data not yet available